Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Sell
2,807,106
-796,501
-22% -$1.4M ﹤0.01% 2189
2026
Q1
$9.84M Sell
3,603,607
-534,644
-13% -$1.11M ﹤0.01% 1565
2025
Q4
$8.28M Buy
4,138,251
+2,146,019
+108% +$4.72M ﹤0.01% 1667
2025
Q3
$3.9M Buy
1,992,232
+256,578
+15% +$418K ﹤0.01% 2021
2025
Q2
$2.29M Buy
+1,735,654
New +$2.03M ﹤0.01% 2244
2024
Q2
Sell
-910,990
Closed -$700K 3369
2024
Q1
$700K Hold
910,990
﹤0.01% 2844
2023
Q4
$1.06M Buy
910,990
+25,855
+3% +$29.5K ﹤0.01% 2704
2023
Q3
$1.05M Sell
885,135
-27,018
-3% -$39.9K ﹤0.01% 2557
2023
Q2
$1.39M Buy
912,153
+343,297
+60% +$444K ﹤0.01% 2511
2023
Q1
$876K Sell
568,856
-38,071
-6% -$72.1K ﹤0.01% 2655
2022
Q4
$1.15M Sell
606,927
-94,003
-13% -$198K ﹤0.01% 2630
2022
Q3
$1.6M Sell
700,930
-18,784
-3% -$52.4K ﹤0.01% 2520
2022
Q2
$1.69M Buy
719,714
+5,268
+0.7% +$19.3K ﹤0.01% 2518
2022
Q1
$3.28M Sell
714,446
-30,143
-4% -$115K ﹤0.01% 2280
2021
Q4
$3.61M Sell
744,589
-44,927
-6% -$275K ﹤0.01% 2284
2021
Q3
$5.29M Sell
789,516
-40,546
-5% -$251K ﹤0.01% 2178
2021
Q2
$6.03M Buy
+830,062
New +$6.07M ﹤0.01% 2149

Other funds holding GEVO

Nuveen's GEVO Position: Q2 2026 in Review

Nuveen reduced its Gevo (GEVO) stake by 22% in Q2 2026, selling an estimated $1.4M and leaving 2,807,106 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

Nuveen first reported a position in GEVO in Q2 2021 and has held it in 17 quarters since. The position peaked at $9.84M in Q1 2026. 148 funds tracked by Wall St. Rank hold GEVO as of Q2 2026.

  • Nuveen held 2,807,106 shares of Gevo worth $4.21M as of Q2 2026.
  • Nuveen sold 796,501 Gevo shares in Q2 2026, an estimated $1.4M.
  • Gevo made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2189 holding.
  • Nuveen first reported a position in Gevo in Q2 2021 and has held it in 17 quarters since.
  • Nuveen's Gevo position peaked at $9.84M in Q1 2026.
  • 148 funds tracked by Wall St. Rank held Gevo as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.